Bumrungrad Hospital Public Company Limited (the “Company”) operates a private hospital business in Bangkok with 580 licensed beds and capacity for over 5,500 outpatients per day. The Company is one of the leading healthcare providers in Thailand and the Southeast Asian region, providing complete healthcare services for both outpatients and inpatients. The Company has always emphasized the importance of quality healthcare and experienced physicians and staff. Bumrungrad International Hospital, Bangkok is the first hospital in Asia to receive the US standard accreditation from the Joint Commission International (JCI). Additionally, the hospital is the first to be approved by Thai Hospital Accreditation (HA), and the first hospital in Thailand to receive accreditations from the College of American Pathologists (CAP) and the first in Asia to receive Det Norske Veritas (DNV) in Managing Infection Risk (MIR).
Unit: Baht Million
|Product line / Business Group||Operated by||% Shareholding by Company||2020||2019||2018|
|Healthcare||Bumrungrad Hospital Pcl.||11,671||93.8||17,516||94.4||17,509||95.1|
|Healthcare||Vitallife Corporation Ltd.||100.0||327||2.6||571||3.1||510||2.8|
|Healthcare||Seoul Seniors Towers LLC||40.8||246||2.0||242||1.3||222||1.2|
|Healthcare||Asia Global Research Ltd.||100.0||35||0.3||53||0.3||-||-|
|Healthcare||Bumrungrad Myanmar Co., Ltd.||80.0||28||0.2||27||0.1||23||0.1|
|Healthcare||Vitallife Allianz Co.,Ltd.||100.0||8||0.1||-||-||-||-|
|Rental||Bumrungrad Hospital Pcl||47||0.4||65||0.4||62||0.3|
|Others||Bumrungrad Hospital Pcl.||49||0.4||60||0.3||70||0.4|
|Others||Vitallife Corporation Ltd.||100.0||3||0.0||5||0.0||4||0.0|
|Others||Asia Global Research Ltd.||100.0||16||0.1||11||0.1||10||0.1|
|Others||Health Horizons Enterprises Pte. Ltd.||80.0||2||0.0||2||0.0||2||0.0|
|Others||Bumrungrad Services Co., Ltd.||100.0||4||0.0||7||0.0||4||0.0|
|Others||Bumrungrad Health Network Co., Ltd.||100.0||9||0.1||-||-||-||-|
Products and services description
Bumrungrad Hospital Public Company Limited (“the Company”)
The Company is the owner and operator of multiple healthcare-related entities, both within and outside of Thailand. They include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, Vitallife Skin Clinic, Bumrungrad International Dialysis Clinic, and Esperance Cancer Clinic, all are in Bangkok; Bumrungrad Clinic Yangon in Myanmar, and Ulaanbaatar Songdo Hospital in Mongolia. Bumrungrad International Hospital is the main revenue contributor.
In 2020, the revenue from hospital operations of the Bangkok facility is 96.8% of total revenues.
The Hospital’s Services:
In 2020, the Company treated more than 0.8 million medical episodes. The revenue contribution by inpatient and outpatient services in 2020:
Inpatient vs. Outpatient (% of total revenue)
In 2020, Bumrungrad treated over 350,000 international medical episodes from over 160 countries. The top three highest revenue contributors by country are Kuwait, Qatar and Myanmar.
The following graph shows the historical revenue contribution of international patients over the past five years.
Thai vs. International patients (% of total revenue)
The Ulaanbaatar Songdo Hospital in Mongolia:
Ulaanbaatar Songdo is one of the leading private hospitals in Mongolia. Strategically located in the center of the country’s capital. The hospital’s services are offered in an 8-storey building, with 88 inpatient beds.